NCT01083732 - Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Venous Thromboembolism

Interventions

DRUG

dabigatran etexilate

Experimental dose chosen based on age and weight

Trial Locations (7)

Boehringer Ingelheim Investigational Site, Ottawa

Boehringer Ingelheim Investigational Site, Roma

Boehringer Ingelheim Investigational Site, Vilnius

Boehringer Ingelheim Investigational Site, Kazan'

Boehringer Ingelheim Investigational Site, Zurich

Boehringer Ingelheim Investigational Site, Bangkok

Boehringer Ingelheim Investigational Site, Khon Kaen